Literature DB >> 16952303

Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia.

Kanji So1, Gen Tamura, Teiichiro Honda, Naoyuki Homma, Takayoshi Waki, Naoyuki Togawa, Satoshi Nishizuka, Teiichi Motoyama.   

Abstract

A number of tumor suppressor and tumor-related genes are silenced by promoter hypermethylation in gastric cancer. Hypermethylation is not restricted to cancer cells, but is also present in non-neoplastic cells during aging. Such age-related methylation in non-neoplastic gastric epithelia is postulated to constitute a field defect that increases the risk for development of gastric cancer. To quantitatively evaluate age-related methylation in non-neoplastic gastric epithelia, we used a fiber-type DNA microarray on which methylated and unmethylated sequence probes were mounted. After bisulfite modification, a part of the promoter CpG island of four tumor suppressor genes, lysyl oxidase (LOX), p16, RUNX3 and tazarotene-induced gene 1 (TIG1), were amplified by PCR using Cy5 end labeled primers. Methylation rates (MRs) were calculated as the ratio of the fluorescence intensity of a methylated sequence probe to the total fluorescence intensity of methylated and unmethylated probes. Non-neoplastic gastric mucosa was obtained from 24 non-cancer-bearing stomachs at autopsy. MRs ranged from 0.0% to 77.2% (mean, 15.8%) for LOX, 0.0% to 45.8% (mean, 10.0%) for p16, 0.0% to 83.8% (mean, 9.0%) for RUNX3, and 0.0% to 46.1% (mean, 6.6%) for TIG1, and significantly correlated with aging (P < 0.01). The regression curves were: y = 0.013x(2) - 0.6184x + 4.0512, R(2) = 0.5728 (P < 0.001) for LOX; y = 0.0107x(2) - 0.6055x + 5.2943, R(2) = 0.7891 (P < 0.00001) for p16; y = 0.0182x(2) - 1.2234x + 11.566, R(2) = 0.5595 (P < 0.001) for RUNX3; and y = 0.0068 x(2) - 0.3586 x + 2.4306, R(2) = 0.4670 (P < 0.01) for TIG1. Thus, our present results are consistent with the notion that age-related methylation is associated with cancer susceptibility in the elderly. Quantitative analysis of DNA methylation using DNA microarrays is a promising method for risk assessment in the development of gastric cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16952303     DOI: 10.1111/j.1349-7006.2006.00302.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  38 in total

Review 1.  Metabolic programming, epigenetics, and gestational diabetes mellitus.

Authors:  Sara E Pinney; Rebecca A Simmons
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

2.  Global heterochromatin loss: a unifying theory of aging?

Authors:  Amy Tsurumi; Willis X Li
Journal:  Epigenetics       Date:  2012-07-01       Impact factor: 4.528

Review 3.  Epigenetic alterations in aging.

Authors:  Susana Gonzalo
Journal:  J Appl Physiol (1985)       Date:  2010-05-06

Review 4.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

5.  Age-associated DNA methylation in pediatric populations.

Authors:  Reid S Alisch; Benjamin G Barwick; Pankaj Chopra; Leila K Myrick; Glen A Satten; Karen N Conneely; Stephen T Warren
Journal:  Genome Res       Date:  2012-02-01       Impact factor: 9.043

Review 6.  Developmental origins of adult disease.

Authors:  Rebecca A Simmons
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

Review 7.  Aging by epigenetics--a consequence of chromatin damage?

Authors:  John M Sedivy; Gowrishankar Banumathy; Peter D Adams
Journal:  Exp Cell Res       Date:  2008-03-12       Impact factor: 3.905

Review 8.  Dark matters in AMD genetics: epigenetics and stochasticity.

Authors:  Leonard M Hjelmeland
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

9.  The influence of aging, environmental exposures and local sequence features on the variation of DNA methylation in blood.

Authors:  Scott M Langevin; E Andres Houseman; Brock C Christensen; John K Wiencke; Heather H Nelson; Margaret R Karagas; Carmen J Marsit; Karl T Kelsey
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

Review 10.  Chromatin modifications: the driving force of senescence and aging?

Authors:  Teresa Dimauro; Gregory David
Journal:  Aging (Albany NY)       Date:  2009-02-13       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.